We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
38 hedge funds and large institutions have $16.5M invested in Zevra Therapeutics in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
275% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 4
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
15% more funds holding
Funds holding: 33 → 38 (+5)
33% less capital invested
Capital invested by funds: $24.4M → $16.5M (-$7.97M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
38
Holders Change
+5
Holders Change %
+15.15%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
15
Reduced
4
Closed
5
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$2K
Top Buyers
| 1 |
DA
DSC Advisors
Chicago,
Illinois
|
+$5.06M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.73M |
| 3 |
CI
Cowen Inc
New York
|
+$506K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$250K |
| 5 |
JGC
J. Goldman & Co
New York
|
+$228K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$498K |
| 2 |
Morgan Stanley
New York
|
-$59.5K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$41.7K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$28.3K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$16.1K |
